Pancreatic Cancer Research

Clinical trialNo phase (not a drug trial)Completed

Intratumoral Holmium Microspheres Brachytherapy for Patients With Pancreatic Cancer

Intratumoral Holmium Microspheres Brachytherapy for Patients With Pancreatic Cancer; a Single Center, Non-randomized, Feasibility Study in an Open Surgical Setting - the SLOTH1 Study

Outcome
Finished, no results posted
Phase
No phase (not a drug trial)
Status
Completed
Study type
Interventional
Start
13 December 2021
Ended
18 February 2024
Enrollment
3 participants
Sites
1
Primary outcomes
Average tumour dose by SPECT imaging
Sponsor type
Academic / other
Results posted
No
Last update
11 April 2024

These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

This is a feasibility study in which patients with pancreatic cancer are treated with intratumoral holmium microsphere injections.